MEDTRONIC PUERTO RICO OPERATIONS CO. INTELLIS; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR
|
Back to Search Results |
|
Model Number 97715 |
Device Problems
High impedance (1291); Energy Output Problem (1431)
|
Patient Problem
Inadequate Pain Relief (2388)
|
Event Date 06/30/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a patient via manufacturer representative who was implanted with an implantable neurostimulator (ins).The patient complained that the stimulation was changing and the therapy wasn't as effective.The patient reported that he had been moving and let the ins deplete for one day so they thought that the issue may be related to that.After device was on they were not getting as effective therapy.The reference was changed to check electrodes 0-7 and all values were >40000ohms.The caller asked about how the leads could become damaged, the leads were occipitally placed.Tss (technical services specialist) reviewed information about leads.The issue was not resolved through troubleshooting.
|
|
Event Description
|
Additional information was received from the manufacturer representative (rep).The cause of high impedances was unknown.The patient has occipital lead placement so possibly just from normal activities and frequent movement of neck/head.The patient is going to have the leads replaced.No date has been set for replacement.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 977a290 lot# serial# (b)(6) implanted: (b)(6) 2019 explanted: (b)(6) 2021 product type lead product id 977a290 lot# serial# (b)(6) implanted: (b)(6) 2019 explanted: (b)(6) 2021 product type lead.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received on august 18, 2021.It was reported the leads were replaced on (b)(6) 2021 and impedances were normal.The rep was advised to return the leads for analysis.The leads were returned and checked in for analysis on august 26, 2021.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 977a290 lot# serial# (b)(6), implanted: (b)(6) 2019, explanted: (b)(6) 2021 h3.Analysis found the conductors 5,6, and 7 were broken 7cm from the distal end.Conductor 0 was broken 3cm from the proximal end.Product type lead product id 977a290 lot# serial#(b)(6) ,implanted: (b)(6) 2019, explanted: (b)(6) 2021 product type lead h3.Analysis found the conductor 2 was broken 4cm from distal end.H6.Evaluation result code 3221 does not apply.Evaluation method code 4117 does not apply.Evaluation conclusion code 67 does not apply.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|